Results 11 to 20 of about 399,293 (360)

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. [PDF]

open access: yesPLoS ONE, 2014
BackgroundInduction chemotherapy is a common therapeutic option for patients with locoregionally-advanced head and neck cancer (HNC), but it remains unclear which patients will benefit. In this study, we searched for biomarkers predicting the response of
Cohen, Ezra EW   +13 more
core   +16 more sources

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care [PDF]

open access: yesCancer Medicine, 2018
The role of induction chemotherapy in nasopharyngeal carcinoma (NPC) remains controversial. The primary aim of this study was to use the National Cancer Database to evaluate the patterns of care of induction chemotherapy in NPC and its impact on overall ...
Adkins, Douglas   +10 more
core   +3 more sources

Randomized Trials of Induction Chemotherapy: A Critical Review

open access: hybridHematology/Oncology Clinics of North America, 1991
There are nine prospective randomized trials comparing induction chemotherapy with standard therapy published in either final form or as preliminary abstract reports. Only one of the six randomized trials critiqued was designed to account for all known prognostic factors, utilized an effective chemotherapy regimen, and had excellent compliance such ...
Arlene A. Forastiere
openaire   +4 more sources

Orbital Myeloid Sarcoma in Acute Myeloid Leukemia: A Case Report [PDF]

open access: yesInternational Journal of Scientific Research in Dental and Medical Sciences, 2022
Orbital myeloid sarcoma is a common presentation in acute myeloid leukemia. A 6 years old girl child presented with progressive proptosis of the left eye for two weeks with associated redness, watering, and reduced vision in the left eye.
Kishalay Baidya   +3 more
doaj   +1 more source

Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma. [PDF]

open access: yesPLoS ONE, 2016
PURPOSE:The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy.
Xiao-Wen Lan   +6 more
doaj   +1 more source

The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study

open access: yesMedicina, 2023
Background and Objectives: This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are ...
Dan Liu   +9 more
doaj   +1 more source

Induction chemotherapy in recurrent, unresectable esthesioneuroblastoma

open access: yesCancer Research, Statistics, and Treatment, 2018
Kumar Prabhash   +4 more
openaire   +4 more sources

Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy

open access: yesWorld Journal of Surgical Oncology, 2022
Background Although patients with positive lavage cytology (CY1) are classified as having stage IV disease, long-term survival without other unresectable factors (P0CY1) has been reported.
Akikazu Yago   +6 more
doaj   +1 more source

Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis

open access: yesFrontiers in Oncology, 2021
BackgroundFluoropyrimidine with platinum-based chemotherapy has become the standard of care for advanced gastric and gastroesophageal (GEJ) cancer.
Daniel Walden   +6 more
doaj   +1 more source

A multicenter randomized phase II trial of hyperthermia combined with TPF induction chemotherapy compared with TPF induction chemotherapy in locally advanced resectable oral squamous cell carcinoma

open access: yesInternational Journal of Hyperthermia, 2021
Background Hyperthermia has been reported to cause cancer stage regression, thus providing surgical opportunities in patients with unresectable tumors and improving the quality of life of patients by preserving certain organs.
Guoxin Ren   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy